Course Director:
- Nicoline Hoogerbrugge (NL)
Organizing Committee:
- Carla Oliveira (PT)
- Hildegunn Høberg-Vetti (NO)
- Elke Holinski-Feder (DE)
- supported by ERN GENTURIS, the VMA team and ESHG
Programme
September 23rd 2021 | 12h15m to 18h15m CEST
| Time | Speaker | Title |
|---|---|---|
| 12.15 - 12.45 | Prof. Nicoline Hoogerbrugge, The Netherlands | 1.01 - What is ERN GENTURIS |
| 12.45 - 13.15 | Prof. Maurizio Genuardi, Italy | 1.02 - The heritability of cancer |
| 13.15 - 13.45 | Prof. Marjolijn Ligtenberg, The Netherlands | 1.03 - The genetic mechanisms of cancer |
| 13.45 - 14.00 | 15 min Break | |
| 14.00 - 14.30 | Prof. Rolf Sijmons, The Netherlands | 1.04 - Panels, exomes and genomes |
| 14.30 - 15.00 | Prof. Marc Tischkowitz, United Kingdom | 1.05 - Hereditary Breast and Ovarian cancer |
| 15.00 - 15.30 | Dr. Claude Houdayer, France | 1.06 - Li-Fraumeni syndrome |
| 15.30 - 16.00 | 30 min Break | |
| 16.00 - 16.30 | Prof.Nicoline Hoogerbrugge, The Netherlands | 1.07 - PHTS (Cowden Syndrome) |
| 16.30 - 17.00 | Prof. Gareth Evans, United Kingdom | 1.08 - Neurocutaneus tumour syndromes |
| 17.00 - 17.15 | 15 min Break | |
| 17.15 - 17.45 | Prof. Marjolijn Jongmans, The Netherlands | 1.09 - Hereditary childhood cancer |
| 17.45 - 18.15 | Dr. Judith Balmaña, Spain | 1.10 - Germline mutations as a therapeutic target in cancer |
September 24th 2021 | 8h30m to 14h00m CEST
| Time | Speaker | Title |
|---|---|---|
| 08.30 - 09.00 | Dr. Tanya Bisseling, The Netherlands | 2.01 - Patient's personal experience |
| 09.00 - 09.30 | Prof. Stefan Aretz, Germany | 2.02 - Polyposis syndromes |
| 09.30 - 10.00 | Prof. Elke Holinski-Feder, Germany | 2.03 - Lynch syndrome |
| 10.00 - 10.15 | 15 min Break | |
| 10.15 - 10.45 | Prof. Carla Oliveira, Portugal | 2.04 - Hereditary gastric cancer |
| 10.45 - 11.15 | Prof. Marjolijn Ligtenberg, The Netherlands | 2.05 - Hereditary prostate cancer |
| 11.15 - 11.45 | Prof. Eamonn Maher, United Kingdom | 2.06 - Hereditary renal cancer & VHL |
| 11.45 - 12.15 | 30 min Break | |
| 12.15 - 12.45 | Dr. Hildegunn Høberg-Vetti, Norway | 2.07 - Familial melanoma & familial pancreatic cancer |
| 12.45 - 13.15 | Prof. Marc Tischkowitz, United Kingdom | 2.08 - Moderate cancer risk genes: testing and clinical management |
| 13.15 - 13.45 | Dr. Svetlana Bajalica Lagercrantz, Sweden | 2.09 - Psycho-oncology in hereditary cancers |
| 13.45 - 14.00 | Wrapping up | |
| 14.00 | End of Meeting |
Registration
Please be informed that the course is already fully booked!
Registration Fee
- EUR 50,-
- Registration is limited to 500 participants
Will the talks be available for an on-demand review after the course?
- Yes, all talks will be available for registered participants until December 24, 2021.
Cancellation
Cancellations and refunds
Notice of cancellation must be made in writing by e-mail to the Congress Office:
hereditary-cancer(at)eshg.org
Registration fees may be refunded if written cancellation has been received as follows:
- until September 1, 2021: 50% refund
- as of September 2, 2021: no refund
The cancellation will not be effective until a written acknowledgement from the Congress Office is received. In the case of over-payment or double payment, refund requests must be made in writing and sent to the Congress Office by e-mail. No refunds will be granted for unattended events or early termination of attendance, in case of cancellation of speakers or any other incidents during the conference, which are beyond the control of the conference organisers.
No exceptions to the refund policy can be made, including health or family issues. By registering for the Digital Edition of the ESHG Course on Hereditary Cancer 2021, participants agree that neither the organising committee nor the congress office assume any liability whatsoever.
Refunds will be made after September 24, 2021
Contact
Congress Office:
WMA GmbH
Registration: Ms. Catherine Tomek
Alser Strasse 4
1090 Vienna, Austria
T: +43 1 405 13 83 18
F: +43 1 405 13 83 918
E: hereditary-cancer(at)eshg.org